Magali Taiel
Company: Gensight-Biologics
Job title: Chief Medical Officer
Seminars:
Chair’s Closing Remarks 3:15 pm
day: Day Two
Running a Gene Therapy Expanded Access Program 1:45 pm
• Understanding the importance of providing an early access program for acute diseases • Using an early access program to provide patients treatments between clinical trials and commercial approval • Considering the additional requirements when running an expanded access program for gene therapiesRead more
day: Day Two
Chair’s Opening Remarks 8:50 am
day: Day Two